One of the most serious consequences of the COVID pandemic for many patients is so called long COVID – long-term sequelae affecting not only hospitalised patients, but also people after mild infection. This worrying trend manifests itself in numerous symptoms – like fever, shortness of breath, and cognitive symptoms with memory and concentration problems, so-called…
Read more
In the new article, professor Bård Reiakvam Kittang, involved in the Bergen COVID-19 Research Group, together with his colleagues looked into the impact of the type of workplace and the use of infection control equipment on healthcare workers’ risk of contracting COVID-19. The differences between the available infection control equipment in municipal health services compared…
Read more
Lena Hansen et al. have recently published a new article “Durable immune responses after BNT162b2 vaccination in home-dwelling old adults” in journal Vaccine: X, where the authors have looked into the durability of humoral and cellular immune responses after BNT162b2 vaccination and SARS-CoV-2 infection in elderly and younger adults. Their research showed that vaccine-induced spike-specific…
Read more
The VACCELERATE Consortium has recently published a new poster informing about its Volunteer Registry, which enables interested persons to register in a volunteer database for clinical trials. The available studies are, among others, connected to COVID-19, polio, influenza and other respiratory infections. Now, the poster is also available in a version for Norway, published in…
Read more
On November 24-25, 2022, the University’s of Bergen Department of Clinical science organized a lunch-to-lunch seminar for young researchers, with support from IBA – The national research school in infection biology and antimicrobials. PhD Candidates, along with postdocs and their supervisors were invited to Voss to explore the theme of the meeting: Effective science communication.…
Read more
Elisabeth Berg Fjelltveit has successfully defended her PhD on November 29, 2022. Her thesis was devoted to “Clinical studies of epidemic influenza and pandemic COVID-19 to improve the chain of patient care: from bedside diagnostics to long-term complications”. Elisabeth responded to questions raised by opponents: Opponent 1 – Doctor Nathan J Brendish, NIHR Clinical Lecturer…
Read more
On November 17, 16:00-20:00 CET the board game “The Pandemic is over…” developed by Science To The People was tested at the local Game centre “Spillhuset” (address: Veiten 3, Norway). The event was open to the general public and you can read more about it on Facebook (in Norwegian): https://www.facebook.com/events/4996120913822768?ref=newsfeed Teenagers and adults both contributed…
Read more
Would you like to extend your knowledge about vaccines and clinical trials in an accessible way? The VACCELERATE project has recently issued 5 sets of educational cards explaining different aspects of vaccine studies. Check them out using the links below: What is a vaccine clinical trial? Do vaccines using mRNA technology use inactivated or weakened…
Read more
This happened at Forskningsdagene 2022. The Influenza Centre participated at Forskningstorget and made large batches of corona vaccine to protect Tina, Eirik, Amalie and Lars. As a result the virus experienced a hard time. Does anyone even care about the well-being of a virus? They are also living creatures – at least according to some.…
Read more
Lena Hansen from the Influenza group has successfully defended her PhD on September 23. Lena defended her dissertation on “Strategies for improving influenza vaccines: insights from the Influenza A H1N1 and SARS-CoV-2 pandemics”. Influenza Centre’s leader, Professor Rebecca J. Cox was her first supervisor, whereas Dr Fan Zhou, Professor Ali Ellebedy and Associate Professor Kristin…
Read more
English